Glypican 3 抗体
(Glypican 3 (GPC3))
Cell surface heparan sulfate proteoglycans are composed of a membrane-associated protein core substituted with a variable number of heparan sulfate chains. Members of the glypican-related integral membrane proteoglycan family (GRIPS) contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol linkage. These proteins may play a role in the control of cell division and growth regulation. The protein encoded by this gene can bind to and inhibit the dipeptidyl peptidase activity of CD26, and it can induce apoptosis in certain cell types. Deletion mutations in this gene are associated with Simpson-Golabi-Behmel syndrome, also known as Simpson dysmorphia syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| Glypican 3 抗体 | 人, 大鼠, 小鼠 | 小鼠 Monoclonal |
|
|
|
| Glypican 3 抗体 | 人, 大鼠 | 小鼠 Monoclonal |
|
|
|
| Glypican 3 抗体 (AA 55-200) | 人, 小鼠 | 小鼠 Monoclonal |
|
|
|
| Glypican 3 抗体 (AA 359-554) | 人 | 小鼠 Monoclonal |
|
|
|
| Glypican 3 抗体 (AA 344-559) | 小鼠 | 兔 Polyclonal |
|
|
|
| Glypican 3 抗体 (AA 55-200) | 人 | 小鼠 Monoclonal |
|
|
|
| Recombinant Glypican 3 抗体 (AA 500-580) | 人, 大鼠 | 小鼠 Monoclonal |
|
|
|
| Glypican 3 抗体 (AA 511-580) | 人 | 小鼠 Monoclonal |
|
|
|
| Glypican 3 抗体 (N-Term) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| Glypican 3 抗体 (AA 359-554) | 人, 大鼠 | 小鼠 Monoclonal |
|
|
|
| Recombinant Glypican 3 抗体 (AA 500-580) | 人, 大鼠 | 兔 Monoclonal |
|
|
|
| Glypican 3 抗体 (AA 343-559) | 人 | 小鼠 Monoclonal |
|
|
|
| Glypican 3 抗体 (AA 343-559) | 人 | 兔 Polyclonal |
|
|
|
| Glypican 3 抗体 | 人, 小鼠 | 小鼠 Monoclonal |
|
|
|
| Glypican 3 抗体 (C-Term) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| Glypican 3 抗体 (N-Term) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| Glypican 3 抗体 (AA 21-50) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| Glypican 3 抗体 (AA 529-560) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| Glypican 3 抗体 (AA 335-365) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| Recombinant Glypican 3 抗体 | 人 | 兔 Monoclonal |
|
|
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- ELISA (ELISA: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- ICC (Immunocytochemistry: 所列应用)
2 references - 适用
- 人, 大鼠, 小鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 9C2
- 标记
- unconjugated
- 抗体亚型
- IgG1
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- 适用
- 人, 大鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- GPC3-863
- 标记
- unconjugated
- 抗体亚型
- IgG1, kappa
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- ELISA (ELISA: 有验证图片)
- 适用
- 人, 小鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 2A2C3
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- AA 55-200
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- ELISA (ELISA: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 2C7E9
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- AA 359-554
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 344-559
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 9C2
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- AA 55-200
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- SDS (SDS-PAGE: 有验证图片)
- PAr (Protein Array: 有验证图片)
- 适用
- 人, 大鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- rGPC3-863
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG1, kappa
- 抗原表位
- AA 500-580
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- SDS (SDS-PAGE: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 1G12
- 标记
- unconjugated
- 抗体亚型
- IgG1, kappa
- 抗原表位
- AA 511-580
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB05031
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 21-50, N-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- ELISA (ELISA: 有验证图片)
- 适用
- 人, 大鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 4D5B1
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- AA 359-554
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- SDS (SDS-PAGE: 有验证图片)
- 适用
- 人, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- GPC3-1534R
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG, kappa
- 抗原表位
- AA 500-580
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- C2
- 标记
- unconjugated
- 抗体亚型
- IgG2a kappa
- 抗原表位
- AA 343-559
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 343-559
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- ELISA (ELISA: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- EIA (Enzyme Immunoassay: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 9C2
- 标记
- unconjugated
- 抗体亚型
- IgG1
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB5038
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 529-560, C-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF/ICC (Immunofluorescence (fixed cells): 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 21-50
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 529-560
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB5036
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 335-365
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- 4H11
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG
Latest Publications for our Glypican 3 抗体
: "Development and in vitro study of a bi-specific magnetic resonance imaging molecular probe for hepatocellular carcinoma." in: World journal of gastroenterology, Vol. 25, Issue 24, pp. 3030-3043, (2019) (PubMed).
: "Identification of Glypican-3 as a potential metastasis suppressor gene in gastric cancer." in: Oncotarget, Vol. 7, Issue 28, pp. 44406-44416, (2018) (PubMed).
: "Autophagy suppresses proliferation of HepG2 cells via inhibiting glypican-3/wnt/β-catenin signaling." in: OncoTargets and therapy, Vol. 11, pp. 193-200, (2018) (PubMed).
: "High-density single cell mRNA sequencing to characterize circulating tumor cells in hepatocellular carcinoma." in: Scientific reports, Vol. 8, Issue 1, pp. 11570, (2018) (PubMed).
: "New tumor suppressor microRNAs target glypican-3 in human liver cancer." in: Oncotarget, Vol. 8, Issue 25, pp. 41211-41226, (2017) (PubMed).
: "Stromal heparan sulfate differentiates neuroblasts to suppress neuroblastoma growth." in: The Journal of clinical investigation, Vol. 124, Issue 7, pp. 3016-31, (2014) (PubMed).
: "Regulation of liver growth by glypican 3, CD81, hedgehog, and Hhex." in: The American journal of pathology, Vol. 183, Issue 1, pp. 153-9, (2013) (PubMed).
: "Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunologic evidence and potential for improving overall survival." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 18, Issue 13, pp. 3686-96, (2012) (PubMed).
: "Soluble glypican 3 inhibits the growth of hepatocellular carcinoma in vitro and in vivo." in: International journal of cancer. Journal international du cancer, Vol. 126, Issue 6, pp. 1291-301, (2010) (PubMed).
: "Involvement of glypican-3 in the recruitment of M2-polarized tumor-associated macrophages in hepatocellular carcinoma." in: Cancer biology & therapy, Vol. 8, Issue 24, pp. 2329-38, (2010) (PubMed).
: "Identification of Glypican-3 as a potential metastasis suppressor gene in gastric cancer." in: Oncotarget, Vol. 7, Issue 28, pp. 44406-44416, (2018) (PubMed).
: "Autophagy suppresses proliferation of HepG2 cells via inhibiting glypican-3/wnt/β-catenin signaling." in: OncoTargets and therapy, Vol. 11, pp. 193-200, (2018) (PubMed).
: "High-density single cell mRNA sequencing to characterize circulating tumor cells in hepatocellular carcinoma." in: Scientific reports, Vol. 8, Issue 1, pp. 11570, (2018) (PubMed).
: "New tumor suppressor microRNAs target glypican-3 in human liver cancer." in: Oncotarget, Vol. 8, Issue 25, pp. 41211-41226, (2017) (PubMed).
: "Stromal heparan sulfate differentiates neuroblasts to suppress neuroblastoma growth." in: The Journal of clinical investigation, Vol. 124, Issue 7, pp. 3016-31, (2014) (PubMed).
: "Regulation of liver growth by glypican 3, CD81, hedgehog, and Hhex." in: The American journal of pathology, Vol. 183, Issue 1, pp. 153-9, (2013) (PubMed).
: "Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunologic evidence and potential for improving overall survival." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 18, Issue 13, pp. 3686-96, (2012) (PubMed).
: "Soluble glypican 3 inhibits the growth of hepatocellular carcinoma in vitro and in vivo." in: International journal of cancer. Journal international du cancer, Vol. 126, Issue 6, pp. 1291-301, (2010) (PubMed).
: "Involvement of glypican-3 in the recruitment of M2-polarized tumor-associated macrophages in hepatocellular carcinoma." in: Cancer biology & therapy, Vol. 8, Issue 24, pp. 2329-38, (2010) (PubMed).
Aliases for Glypican 3 抗体
glypican 3 (gpc3) 抗体glypican 3 (GPC3) 抗体
glypican 3 (Gpc3) 抗体
dgsx 抗体
DGSX 抗体
Glypican-3 抗体
GPC3 抗体
GTR2-2 抗体
MXR7 抗体
oci-5 抗体
OCI-5 抗体
sdys 抗体
SDYS 抗体
sgb 抗体
SGB 抗体
sgbs 抗体
SGBS 抗体
sgbs1 抗体
SGBS1 抗体
您还需要查找其他产品吗？
- Glyoxylate Reductase/hydroxypyruvate Reductase 抗体
- GLYCTK 抗体
- Glycosyltransferase 25 Domain Containing 1 抗体
- Glycosylphosphatidylinositol Specific phospholipase D1 抗体
- Glycoprotein Xg 抗体
- Glycoprotein M6B 抗体
- Glycoprotein M6A 抗体
- Glycogenin 2 抗体
- Glycogenin 1 抗体
- Glycogen Synthase Kinase 3 抗体
- Glycogen Synthase 2 抗体
- Glycogen Synthase 1 抗体
- Glycogen Synthase 抗体
- Glycine Receptor 抗体
- Glycine Cleavage System H Protein 抗体
- Glycerol-3-Phosphate Dehydrogenase 1 (Soluble) 抗体
- Glycerol Kinase 抗体
- Glyceraldehyde-3-Phosphate Dehydrogenase 抗体
- GLYATL3 抗体
- GLYATL2 抗体
You are here:
